Microfluidics: a transformational tool for nanomedicine development and production.
Shyam Garg1, Gesine Heuck1, Shell Ip1
1a Precision NanoSystems Inc , Vancouver , BC , Canada.
Journal of Drug Targeting
|August 6, 2016
Summary
Microfluidic devices offer precise control for creating drug-delivery nanoparticles like lipid nanoparticles and liposomes. This technology enables scalable, reproducible, and optimized nanomedicine production for enhanced therapeutic delivery.
Area of Science:
- Nanotechnology
- Materials Science
- Pharmaceutical Sciences
Background:
- Microfluidic devices manipulate fluids at the nanoliter scale.
- Their controlled mixing and continuous flow are ideal for nanoparticle formulation.
- Conventional methods like beaker mixing have limitations in precision and scalability.
Purpose of the Study:
- To review microfluidic designs for formulating and producing various nanoparticles.
- To highlight the advantages of microfluidics over traditional methods for nanomedicine.
- To emphasize the optimization and scalability benefits for drug delivery systems.
Main Methods:
- Review of literature on microfluidic applications in nanoparticle formulation.
- Comparison of microfluidic approaches with conventional methods (beaker, T-tube mixing).
- Analysis of microfluidic designs for lipid nanoparticles, liposomes, and polymer nanoparticles.
Main Results:
- Microfluidics allows fine control over parameters, optimizing nanoparticle quality and encapsulation efficiency.
- Automated microfluidic systems improve formulation reproducibility.
- Continuous microfluidic processes are scalable, enabling efficient production from low volumes.
Conclusions:
- Microfluidics provides superior control and optimization for nanoparticle formulation compared to conventional methods.
- The inherent scalability of microfluidics facilitates efficient nanomedicine production.
- Microfluidics is set to revolutionize nanomedicine formulation and manufacturing.
